François Goldwasser
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 49
- Colorectal Cancer Treatments and Studies 41
- Cancer Immunotherapy and Biomarkers 30
- Geriatrics and Gerontology top 1%
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 20
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 17
-
- Renal cell carcinoma treatment 29
- Lung Cancer Treatments and Mutations 21
-
- Cancer therapeutics and mechanisms 23
- Co-authors
- Olivier MirJérôme AlexandreStanislas RopertPascaline Boudou‐RouquetteBenoı̂t BlanchetRomain CoriatFrédéric BatteuxCarole Nicco
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Investigation (1 paper)Journal of Clinical Oncology (44 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
François Goldwasser
275 papers receiving 8.7k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 4.7k
- Geriatrics and Gerontology 313
- Hepatology 618
- Cancer Research 973
- Pulmonary and Respiratory Medicine 2.1k
Countries citing papers authored by François Goldwasser
This map shows the geographic impact of François Goldwasser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Goldwasser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Goldwasser more than expected).
Fields of papers citing papers by François Goldwasser
This network shows the impact of papers produced by François Goldwasser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Goldwasser. The network helps show where François Goldwasser may publish in the future.
Co-authorship network
The 25 scholars most cited alongside François Goldwasser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 13 | |
| 6 | 2023 | 19 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 18 | |
| 12 | 2021 | 16 | |
| 13 | 2021 | 10 | |
| 14 | 2019 | 33 | |
| 15 | 2018 | 251 | |
| 16 | 2017 | 59 | |
| 17 | 2016 | 4 | |
| 18 | 2013 | 64 | |
| 19 | 2012 | 170 | |
| 20 | 2005 | 422 |
About François Goldwasser
François Goldwasser is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 289 papers that have together received 8.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (49 papers), Colorectal Cancer Treatments and Studies (41 papers), Cancer Immunotherapy and Biomarkers (30 papers), Renal cell carcinoma treatment (29 papers), Cancer therapeutics and mechanisms (23 papers), Lung Cancer Treatments and Mutations (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers) and Cancer Genomics and Diagnostics (17 papers). The work is most often cited by research in Oncology (4.7k citations), Geriatrics and Gerontology (313 citations) and Hepatology (618 citations). François Goldwasser has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Olivier Mir, Jérôme Alexandre, Stanislas Ropert, Pascaline Boudou‐Rouquette, Benoı̂t Blanchet, Romain Coriat, Frédéric Batteux, Carole Nicco, Christiane Chéreau and Bernard Weill. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.